Absence of apolipoprotein E4 genotype, good gallbladder motility and presence of solitary stones delay rather than prevent gallstone recurrence after extracorporeal shock wave lithotripsy

Journal of Hepatology

Volumn 35, Issue 1, 2001, Pages 10-16

  Venneman, Niels G ^a   VanBerge Henegouwen, Gerard P ^a   Portincasa, Piero ^b   Stolk, Mark F J ^a   Vos, Aart ^a   Plaisier, Peter W ^c   Van Erpecum, Karel J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b POLICLINICO   (Italy)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

ApoE4 genotype; Extracorporeal shock wave lithotripsy; Gallstone; Non steroidal anti inflammatory drugs; Recurrence; Ursodeoxycholic acid

Indexed keywords

APOLIPOPROTEIN E4; NONSTEROID ANTIINFLAMMATORY AGENT; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; CHOLESTEROL STONE; CONTROLLED STUDY; EXTRACORPOREAL LITHOTRIPSY; FEMALE; FOLLOW UP; GALLBLADDER EMPTYING; GALLBLADDER MOTILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CHOLELITHIASIS; FEMALE; FOLLOW-UP STUDIES; GALLBLADDER; GENOTYPE; HUMANS; LITHOTRIPSY; MALE; MIDDLE AGED; PATIENT SATISFACTION; RECURRENCE; TIME FACTORS;

EID: 0034933527     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(01)00093-9     Document Type: Article

References (37)

1. Shock-wave lithotripsy of gallbladder stones. The first 175 patients
2. The Munich gallbladder lithotripsy study. Results of the first 5 years with 711 patients
3. Gallstone disappearance after extracorporeal lithotripsy and oral bile acid dissolution
4. Piezoelectric lithotripsy: Stone disintegration and follow-up results in patients with symptomatic gallbladder stones
5. Gallstone recurrence after successful lithotripsy
6. Gallstone recurrence after shock-wave therapy
7. Recurrent gallstone formation after successful extracorporeal shock-wave lithotripsy
8. Gallbladder emptying and gallstone formation: A prospective study on gallstone recurrence
9. Apolipoprotein E4 genotype and gallbladder motility influence speed of gallstone clearance and risk of recurrence after extracorporeal shock-wave lithotripsy
10. Aspirin prevention of cholesterol gallstone formation in prairie dogs
11. Prevention of gallstone recurrence by non-steroidal anti-inflammatory drugs
12. Can aspirin prevent gallstone recurrence after successful extracorporeal shockwave lithotripsy?
13. Electromagnetic shock wave lithotripsy of gallbladder stones: A wide range of inclusion criteria
14. Gallstone lithotripsy: The Rotterdam experience
15. Prevalence of gallstone disease in an Italian adult female population
16. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia
17. Functional gastroduodenal disorders
18. Apolipoprotein E2/E3/E4 genotyping with agarose gels
19. Critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction
20. Nonparametric estimation from incomplete observations
21. Symptoms of post-extracorporeal shock wave lithotripsy: Long-term analysis of gallstone patients before and after successful shock wave lithotripsy
22. Gallstone recurrence after successful shock wave therapy. The magnitude of the problem and the predictive factors
23. Gallstone recurrence after successful oral bile acid treatment
24. 10-Year-follow-up of gallstone recurrence after successful extracorporeal shockwave lithotripsy (ESWL)
25. Recurrence and re-recurrence of gallstones after medical dissolution: A long term follow-up
26. Gallstone recurrence after medical dissolution: An over-estimated threat?
27. Characteristics of recurrent gallstones following non-surgical treatment: Implications for retreatment
28. Cholesterol nucleation time in gallbladder bile of patients with solitary or multiple cholesterol gallstones
29. Cholesterol crystallization in human gallbladder bile: Relation to gallstone number, bile composition, and apolipoprotein E4 isoform
30. Gallbladder stone recurrence after medical treatment. Do gallstones recur true to type?
31. Gallstone cholesterol content is related to apolipoprotein E polymorphism
32. Apolipoprotein E polymorphism and gallstones
33. Effects of ursodeoxycbolic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight
34. Prophylaxis against gallstone formation with ursodeoxycholic acid in patients participating in a very-low-calorie diet program
35. Gall stone recurrence and its prevention: The British/Belgian gall stone study group's post-dissolution trial
36. Gallstone recurrence after successful dissolution therapy
37. Indomethacin and postprandial gallbladder emptying